Telix Pharmaceuticals | Betriebsergebnis



Operating Profit Veränderung Datum
Cochlear AUD 220.1M 34.8M 2024-06
CSL USD 1.2B 1.41B 2024-06
Ecofibre AUD -4680000 38.98M 2024-06
Integral Diagnostics AUD 19.28M 73.95M 2024-06
Mayne Pharma AUD -3300000 15.67M 2024-06
Medical Developments International AUD -20243000 7.24M 2024-06
Mesoblast -45727000 22.22M 2024-06
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Pacific Edge NZD -15314000 7.45M 2024-09
Paradigm Biopharmaceuticals AUD -9718700 39.15M 2024-06
Polynovo AUD 513K 902K 2024-06
PYC Therapeutics AUD -11710000 3.21M 2024-06
Ramsay Health Care AUD 200M 285.4M 2024-12
ResMed USD 417.24M 29.93M 2024-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12



Telix Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.